Guidance
Company raised 2025 adjusted EBITDA guidance by $450 million
Guidance · revenue to $75.75B
← Back to feed
01
02
03
04
AI
Demand
Capex
HCA
FY2025 Q3
RAISED
HCA Healthcare, Inc. earnings call
Buzzberg read
Company raised 2025 adjusted EBITDA guidance by $450 million
HCA reported strong Q3 2025 results with 42% adjusted EPS growth and raised full-year guidance. Management cited broad-based volume growth, improved payer mix, and significant Medicaid supplemental payment benefits. They expressed confidence in 2026 demand within the 2-3% volume growth range while noting uncertainty around federal enhanced premium tax credits. Operational efficiencies and a robust resiliency program continue to support margin expansion. Revenue increased 9.6% in Q3; adjusted EBITDA raised $450M at midpoint for FY2025, split between $250M from supplemental payments and $200M from operations.
Buzzberg read Company raised 2025 adjusted EBITDA guidance by $450 million HCA reported strong Q3 2025 results with 42% adjusted EPS growth and raised full-year guidance. Management cited broad-based volume growth, improved payer mix, and significant Medicaid supplemental payment benefits. They expressed confidence in 2026 demand within the 2-3% volume growth range while noting uncertainty around federal enhanced premium tax credits. Operational efficiencies and a robust resiliency program continue to support margin expansion. Revenue increased 9.6% in Q3; adjusted EBITDA raised $450M at midpoint for FY2025, split between $250M from supplemental payments and $200M from operations. Read full analysisCollapse analysis
HCA reported strong Q3 2025 results with 42% adjusted EPS growth and raised full-year guidance. Management cited broad-based volume growth, improved payer mix, and significant Medicaid supplemental payment benefits. They expressed confidence in 2026 demand within the 2-3% volume growth range while noting uncertainty around federal enhanced premium tax credits. Operational efficiencies and a robust resiliency program continue to support margin expansion. Revenue increased 9.6% in Q3; adjusted EBITDA raised $450M at midpoint for FY2025, split between $250M from supplemental payments and $200M from operations.
- Same-facility equivalent admissions grew 2.4%; commercial admissions up 3.7%, Medicare up 3.4%; ER visits up 1.3% despite a slow respiratory season.
- Medicaid supplemental payment net benefit in Q3 was $240M higher YoY, driven by Tennessee, Kansas, and Texas approvals; FY2025 guide includes $250-350M net benefit improvement.
- Hurricane-impacted markets (North Carolina) are still recovering; FY2025 expected to recapture $100M of the $250M EBITDA hit from 2024, with most in Q4.
Revenue
$19.161B
reported
EPS
$6.96
reported
Gross margin
41.83%
reported
Op margin
15.47%
reported
What changed this quarter
Demand
Expects health services volumes within long-term 2-3% growth range
Management expressed confidence in the company's positioning, citing strong operational performance, diversified portfolio, and ongoing investments in resiliency and technology.
Margins
Resiliency program enhanced and accelerated for future
Reported gross margin was 41.83%, reinforcing the quarter's better-than-guided profitability.
Demand
Medicare Advantage volumes up 4.8% year-over-year
Expects health services volumes within long-term 2-3% growth range. Management expressed confidence in the company's positioning, citing strong operational performance, diversified portfolio, and ongoing investments in resiliency and technology.
AI, capex & demand read
Platform & monetization
Management discussed the use of AI and digital tools in revenue cycle management, focusing on responding to payer denials, and noted piloting ambient AI documentation tools for physicians.
Bookings & conversion
Expects health services volumes within long-term 2-3% growth range. Management expressed confidence in the company's positioning, citing strong operational performance, diversified portfolio, and ongoing investments in resiliency and technology.
Investment and capacity
Capital expenditures for 2025 are expected to be approximately $5 billion. Management indicated more capital is coming online in 2026, which will add physical capacity and align with workforce capacity to accommodate anticipated demand.
Tone · Confident
Management expressed confidence in the company's positioning, citing strong operational performance, diversified portfolio, and ongoing investments in resiliency and technology.
Forward guidance
RaisedGuidance · revenue to $75.75B
| Metric | Period | Range | Midpoint | Status |
|---|---|---|---|---|
| Capex | FY2025 | $5B | $5B | MAINTAINED |
| EPS | FY2025 | $27.00–$28.00 | $27.50 | RAISED |
| Op margin | FY2025 | $15.25B–$15.65B | $15.45B | RAISED |
| Revenue | FY2025 | $75B–$76.5B | $75.75B | RAISED |
Guidance credibility
100%historical hit rate
100%
Mike Marks
1 of 1 · -2.0% average bias